(5R)-5-(Trifluoromethyl)pyrrolidin-2-one, 97.0%, 5g

GC capillary column ROTI®Cap-5 MS Ultra, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S)-, 98%, 5mg

N-(2-bromo-5-methoxyphenyl)acetamide, 97%, 1g

METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-2-(OXETAN-3-YL)ACETATE, 95.0%, 10g

(R)-3-Methylmorpholine hydrochloride, 95.0%, 25g

4-(1-Pyrrolidinyl)benzonitrile, 95.0%, 5g

Ethyl 1-(4-bromophenyl)-1H-imidazole-5-carboxylate, 97%, 100mg

1-(Tetrahydro-2H-pyran-2-yl)-1H-pyrazole-5-boronic acid pinacol ester, 97.0%, 25g

2-(1-{[(tert-Butoxy)carbonyl]amino}cyclopropyl)acetic acid, 95%, 250mg

2,4-Dibromobenzoic Acid>98.0%(GC)(T)5g

5-(4-Chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid, 97.0%, 500g

N-Boc-2-(2-amino-ethoxy)-ethylamine hydrochloride, 98.0%, 2.5g